Natco Pharma

Midcap Marico, 5 smallcap stocks with 'Double Bottom' pattern on charts

Among smallcaps - Natco Pharma, Neuland Laboratories, Inox India, Welspun Living and GE Shipping shares have witnessed the formation of 'Double Bottom' pattern on the technical charts.

Natco Pharma share price rises 5% on rating update; check key details here

Natco Pharma, in a regulatory filing, has informed the exchanges that the credit rating agency ICRA Limited has reaffirmed and assigned credit ratings for Natco Pharma's various debt instruments.

Natco Pharma shares drop as Chennai plant receives USFDA observations

Natco Pharma shares fell 2 per cent as it received seven observations in the Form-483 from the US Food and Drug Administration

Stocks to Watch today, Nov 24: HUL, TCS, RVNL, HG Infra, Marico

Stocks to Watch today, November 24, 2025: From RVNL to HUL, here is a list of stocks that will be on investors' and traders' radar

Natco Pharma Q2 results: Consolidated net profit down 23.44% at ₹517.9 cr

Natco Pharma Ltd on Friday reported a 23.44 per cent decline in consolidated net profit at Rs 517.9 crore in the second quarter ended September 30, 2025, impacted by higher R&D expenses and one-time employee bonus. The company had posted a consolidated net profit of Rs 676.5 crore in the same quarter of the previous fiscal, Natco Pharma said in a regulatory filing. Consolidated revenue from operations in the second quarter stood at Rs 1,363 crore, as against Rs 1,371.1 crore in the corresponding period last fiscal, it added. Total expenses in the quarter under review stood at Rs 849.3 crore, as compared to Rs 616.7 crore in the same period a year ago, the company said. During the quarter, the company incurred substantial R&D expenses on bioequivalence and one-time employee bonuses, in addition to other business-related provisions, Natco Pharma said. Formulations export revenue was lower at Rs 1,147 crore in the second quarter, compared to Rs 1,211.3 crore in the year-ago ...

Roche moves SC against Delhi HC nod to Natco for Risdiplam generic

The Swiss pharma company has challenged a Delhi High Court ruling that allowed Natco Pharma to sell a generic version of its spinal muscular atrophy drug Risdiplam

Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal

The buying on the counter came after the Delhi High Court dismissed an appeal by F. Hoffmann-La Roche AG, removing the last legal hurdle for Natco Pharma to launch a generic version of Risdiplam

Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI

Natco Pharma stock was trading at ₹884.5, up 3.2 per cent compared to the previous session's close of ₹857.25 on the NSE

Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?

Among stocks, Natco Pharma plunged 37.85%, Ipca Labs 22.43%, Aurobindo Pharma 17.99%, and Sun Pharma 14.30%. Other laggards include Lupin (13.25%), and Dr Reddy's (5.17%).

Fancy dividends? Keep an eye on these 11 stocks today; check full list here

Here is the complete list of stocks that will remain in focus today as they trade ex-dividend on August 19, along with their key details

Dr Reddy's Labs, Lupin: Nifty Pharma slips 2% amid Trump tariff jitters

Nifty Pharma index declined 1.5 per cent in trade after US President Donald Trump warned to impose a 25 per cent tariff on Indian goods starting August 1

Natco Pharma offers to acquire 35% in Adcock Ingram for ₹2,000 crore

The proposed Rs 2,000 crore deal will give Natco Pharma a strategic foothold in South Africa, with transaction completion expected within four months subject to approvals

Stock calls, July 4: Natco Pharma, Sharda Cropchem among top stocks to buy

Stocks to buy: Analyst pick Sharda Cropchem, Monarch Networth Capital and one more share to buy; Check full details

Why did Natco Pharma's share price slip 3% in trade today? Details here

Natco Pharma shares slipped in trade after the company said that the USFDA has issued one (1) observation in the Form-483 for its API manufacturing plant in Mekaguda, Hyderabad.

Stocks to Watch today, June 16, 2025: Ireda, DLF, OMCs, IndusInd Bk

Stocks to Watch today, June 16, 2025: From Ireda to oil-linked stocks, here is a list of few shares that will remain on investors' radar today

Here's why Natco Pharma share price is buzzing in trade on Thursday, May 29

Natco Pharma share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

Delhi HC tells Natco Pharma to pause launch of generic version of Risdiplam

Roche had appealed against a single judge order of March 24 that had refused to stop Natco Pharma from manufacturing a generic version of Risdiplam

Natco Pharma trades lower for 10th straight day; tanks 40% on weak Q3

The pharma stock hit its lowest level since December 2023 and tanked 52 per cent from its record high level of Rs 1,638.35, touched on September 12, 2024.

Nifty Pharma tanks 3% on Trump's tariff threat; Zydus, Lupin down upto 10%

The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of around 25 per cent on pharmaceutical, automobile, and semiconductor imports

Nifty Pharma index slips 3%; Natco, Glenmark, Lupin, Laurus down up to 10%

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.